Evoke Pharma Stock (NASDAQ:EVOK)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.20

52W Range

$3.54 - $17.88

50D Avg

$4.84

200D Avg

$6.85

Market Cap

$4.30M

Avg Vol (3M)

$68.63K

Beta

0.39

Div Yield

-

EVOK Company Profile


Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Sep 25, 2013

Website

EVOK Performance


EVOK Financial Summary


Dec 23Dec 22Dec 21
Revenue$5.18M$2.51M$1.62M
Operating Income$-7.43M$-7.79M$-8.15M
Net Income$-7.79M$-8.16M$-9.03M
EBITDA$-7.43M$-7.72M$-8.14M
Basic EPS$-2.33$-2.60$-3.37
Diluted EPS$-2.33$-2.60$-3.37

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 23Mar 14, 24 | 9:33 PM
Q4 22Mar 21, 23 | 6:39 PM
Q3 22Nov 09, 22 | 8:46 PM

Peer Comparison


TickerCompany
AKANAkanda Corp.
BFRIBiofrontera Inc.
AQSTAquestive Therapeutics, Inc.
GHSIGuardion Health Sciences, Inc.
IXHLIncannex Healthcare Limited
RGCRegencell Bioscience Holdings Limited
SHPHShuttle Pharmaceuticals Holdings, Inc.
DERMJourney Medical Corporation
ACRXTalphera, Inc.
PTPIPetros Pharmaceuticals, Inc.
CPIXCumberland Pharmaceuticals Inc.
PROCProcaps Group S.A.
JUPWSafety Shot Inc
ADMPAdamis Pharmaceuticals Corporation
PRFXPainReform Ltd.
AGRXAgile Therapeutics, Inc.
AVDLAvadel Pharmaceuticals plc
EGRXEagle Pharmaceuticals, Inc.